Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer

NCT00297596 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Trastuzumab
DRUG: Oxaliplatin

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]